A look at Canadian issues moving on early news
Miranda Gold Corp. (MAD-X), which lost 6 per cent yesterday, announced today that Phase III drilling was completed at Big Blue, a sediment-hosted gold project in Lander County. The company said both holes intersected anomalous gold mineralization in the carbonate section of the lower plate of the Roberts Mountains Thrust.
Sama Resources Inc. (SME-X) today reported mineral resource estimates for Samapleu deposits. This maiden mineral resource includes an indicated mineral resource of 12.5 million tonnes grading 0.24 per cent Ni and 0.23 per cent Cu and containing 66.4 million pounds of Ni and 61.0 million pounds of Cu.
D-BOX Technologies Inc. (DBO-T), which fell 6 per cent yesterday, today said its net loss for the fourth quarter 2012 was $1.8-million, up from the previous year's $1.2-million. Revenues were $2.6-million, up from $2.3-million last year.
Yukon-Nevada Gold Corp. (YNG-T) announced that the Board of Directors has accepted the resignation of Robert F. Baldock as president and CEO. Shaun Heinrichs, chief financial officer, and Randy Reichert, chief operating officer, will jointly assume the roles of president and CEO while continuing to act in their existing roles within the company.
Reitmans (Canada) Ltd. (RET-T) announced a partnership with Babies "R" Us to provide Thyme Maternity apparel and accessories in the U.S. Thyme Maternity products are expected to be made available in approximately 160 U.S. Babies "R" Us stores later this year.
Whitecap Resources Inc. (WCP-T), which lost nearly 6 per cent yesterday, provided an operations update along with a revised outlook for 2012 based on a reduced capital program for the balance of the year.
Freegold Ventures Ltd. (FVL-T), which fell more than 5 per cent and closer to a year low 50 cents yesterday, said it intersected 1.57 g/t Au over 136.7 metres at Golden Summit Project, Alaska.
Bellatrix Exploration Ltd. (BXE-T) announced updated 2012 capital expenditure plans and guidance.
Spectral Diagnostics Inc. (SDI-T), which is trading near a year low of 19 cents, announced that the U.S. Food and Drug Administration approved the company's request to add up to an additional 30 clinical trial sites to its Phase III EUPHRATES trial.
Wheels Group Inc. (WGI-X) said comprehensive loss for the first quarter was $1.1-million or $0.01 per share, compared with comprehensive income for the same period in 2011 of $0.1-million or $2.03 per share. It said this decrease was primarily due to the increase in gross margin being offset by the increase in personnel and other operating expenses, stock based compensation along with increased amortization of intangibles and dividends on preference shares.
Follow us on Twitter: